HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Jacobus P Petzer Selected Research

Monoamine Oxidase (MAO)

11/2015Monoamine oxidase inhibitory activities of heterocyclic chalcones.
5/2015The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase.
4/2015The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
1/20153-Coumaranone derivatives as inhibitors of monoamine oxidase.
1/2015Novel monoamine oxidase inhibitors: a patent review (2012 - 2014).
1/2015Caffeine as a lead compound for the design of therapeutic agents for the treatment of Parkinson's disease.
1/20152-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
11/2012Novel sulfanylphthalimide analogues as highly potent inhibitors of monoamine oxidase B.
9/2012Selected chromone derivatives as inhibitors of monoamine oxidase.
3/2012Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Jacobus P Petzer Research Topics

Disease

19Parkinson Disease (Parkinson's Disease)
11/2015 - 09/2002
10Neurodegenerative Diseases (Neurodegenerative Disease)
11/2015 - 11/2009
4Alzheimer Disease (Alzheimer's Disease)
04/2015 - 02/2014
2Catalepsy
11/2015 - 08/2013
2Nervous System Diseases (Neurological Disorders)
01/2015 - 10/2010
2Neoplasms (Cancer)
01/2015 - 11/2003
1Cocaine-Related Disorders (Cocaine Addiction)
01/2015
1Inflammation
01/2015
1Bipolar Disorder (Mania)
11/2014
1Mental Disorders (Mental Disorder)
07/2014
1Dyskinesias (Dyskinesia)
01/2009
1Hepatocellular Carcinoma (Hepatoma)
11/2003

Drug/Important Bio-Agent (IBA)

13Monoamine Oxidase (MAO)IBA
11/2015 - 01/2009
4Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
08/2013 - 09/2002
3Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA
10/2015 - 01/2015
3Dopamine (Intropin)FDA LinkGeneric
04/2015 - 12/2003
3Caffeine (No Doz)FDA LinkGeneric
01/2015 - 09/2002
2Haloperidol (Haldol)FDA LinkGeneric
11/2015 - 08/2013
2AdenosineFDA LinkGeneric
04/2015 - 01/2009
2Methylene Blue (Methylthioninium Chloride)FDA Link
11/2014 - 02/2014
1ChalconesIBA
11/2015
1TetralonesIBA
10/2015
1Purinergic P1 Receptors (Adenosine Receptor)IBA
04/2015
1Biological Markers (Surrogate Marker)IBA
01/2015
1crocinIBA
07/2014
1OxidoreductasesIBA
07/2014
1EnzymesIBA
07/2014
1safranalIBA
07/2014
1Azure BIBA
02/2014
1XanthineIBA
08/2013
1Protein Isoforms (Isoforms)IBA
11/2012
1ChromonesIBA
03/2012
1indoleIBA
10/2010
1benzofuranIBA
10/2010
1Nitric Oxide Synthase (NO Synthase)IBA
11/2009
1Levodopa (L Dopa)FDA LinkGeneric
01/2009
1Dopamine Agonists (Dopamine Agonist)IBA
12/2003
1Transcription Factors (Transcription Factor)IBA
11/2003
1Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA
11/2003
1LuciferasesIBA
11/2003
1oltiprazIBA
11/2003
1Purinergic P1 Receptor AntagonistsIBA
04/2003
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
09/2002

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2009